Skip to main content
BioInvent International logo

BioInvent International — Investor Relations & Filings

Ticker · BINV ISIN · SE0015244520 LEI · 549300E7QRHEF2IJUY10 ST Manufacturing
Open in API
Filings indexed 679 across all filing types
Latest filing 2017-04-12 Annual Report
Country SE Sweden
Listing ST BINV

About BioInvent International

https://www.bioinvent.com/en

BioInvent International is a clinical-stage company that discovers and develops novel, first-in-class immuno-modulatory antibodies for cancer therapy. Leveraging extensive expertise in immunology, cancer biology, and antibody biology, the company generates innovative immuno-oncology drug candidates for its clinical pipeline. BioInvent's operations include an in-house manufacturing facility to produce antibodies for its preclinical studies and clinical trials, with the goal of developing treatments that can transform the lives of cancer patients.

Recent filings

Filing Released Lang Actions
Annual Report 2016
Annual Report Classification · 100% confidence The document is titled 'ÅRSREDOVISNING' (Annual Report in Swedish) and contains comprehensive sections typical of an annual report, including a CEO statement, business strategy, clinical pipeline, and full financial statements (consolidated and parent company) for the fiscal year 2016. It is clearly the full annual report, not an announcement or summary. FY 2016
2017-04-12 Swedish
Annual Report 2016
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT' and contains a comprehensive table of contents covering business strategy, CEO comments, financial statements (consolidated statement of comprehensive income, financial position, cash flows), auditor's reports, and corporate governance. It covers the full fiscal year 2016 and provides detailed financial data, meeting the criteria for an Annual Report (10-K). FY 2016
2017-04-12 English
Annual General Meeting in BioInvent International AB
AGM Information Classification · 100% confidence The document is explicitly titled 'Annual General Meeting in BioInvent International AB' and details the date, location, notice requirements, and the full agenda for the meeting. The agenda items cover elections, approval of financial statements (item 8), appropriation of results (item 9), and resolutions regarding remuneration, share programs, and warrants (items 10-16). This content is characteristic of materials distributed for an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2017-04-12 English
Kallelse till årsstämma i BioInvent International AB
AGM Information Classification · 100% confidence The document is titled "Kallelse till årsstämma i BioInvent International AB" (Notice of Annual General Meeting in BioInvent International AB) and details the date, time, location, and agenda for the meeting. The agenda items (Points 1 through 17) cover standard AGM topics such as electing the chairman, approving the agenda, reviewing the annual report (item 8a), deciding on profit distribution (item 9b), electing the board, setting remuneration (items 10-13), and approving various incentive programs (items 14 and 15). This content is characteristic of a formal notice and agenda for an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2017-04-12 Swedish
Earnings Release 2016
Earnings Release Classification · 99% confidence The document is titled "BioInvent bokslutskommuniké 1 januari – 31 december 2016" (BioInvent Year-End Report 1 January – 31 December 2016) and provides detailed financial figures for the fourth quarter and the full year 2016, including Net Sales, Net Income, Earnings Per Share, and Cash Flow. It also discusses significant business events and the clinical pipeline. This structure and content clearly indicate a comprehensive annual financial report, which corresponds to the definition of an Annual Report (10-K), although the document itself is a press release summarizing the results, the core content is the annual financial performance summary. Given the options, '10-K' is the most appropriate classification for the underlying content type being reported, even if this specific document is the release (which might sometimes be classified as ER or RPA, but the scope here is the full year's performance). Since it covers the full fiscal year and contains detailed financial statements/summaries, it aligns best with the Annual Report category. FY 2016
2017-02-15 Swedish
Earnings Release 2016
Earnings Release Classification · 99% confidence The document is titled 'BioInvent Financial Statement' and provides detailed financial figures for the 'Full year report 2016, January - December', including Net sales, Profit/loss after tax, Earnings per share, and Cash flow. It also includes commentary from the CEO and a detailed pipeline update. This structure is characteristic of a comprehensive annual financial report, although it is presented as a 'Press release'. Given the depth of the full-year financial data and the context of a year-end review, it aligns best with the Annual Report category (10-K), even if it is a summary press release version, as it covers the entire fiscal year's performance. However, since it is explicitly labeled as a 'Press release' and contains key financial highlights rather than the full regulatory filing structure of a 10-K, it is more accurately classified as an Earnings Release (ER) or potentially an Interim/Quarterly Report (IR) if it were quarterly. Since it covers the full year and contains extensive financial details, it functions as the primary announcement of the annual results. Given the options, 'ER' (Earnings Release) is the closest fit for a press release announcing period results, even if it covers the full year, as it is not the formal 10-K filing itself. If the document were significantly longer and contained all required regulatory disclosures, 10-K would be appropriate. Based on the format (Press release format summarizing full-year results), ER is the most suitable classification. FY 2016
2017-02-15 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.